Fulgent Genetics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of FLGT for the last quarter is 70.50 M USD, and it's 16.75% lower compared to the previous quarter. The net income of Q4 23 is -128.15 M USD.